WallStSmart

Cellebrite DI (CLBT)vsTurtle Beach Corporation (TBCH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cellebrite DI generates 66% more annual revenue ($496.43M vs $298.19M). CLBT leads profitability with a 14.5% profit margin vs 0.4%. CLBT trades at a lower P/E of 54.9x. TBCH earns a higher WallStSmart Score of 43/100 (D).

CLBT

Hold

40

out of 100

Grade: F

Growth: 6.7Profit: 6.0Value: 3.0Quality: 6.5
Piotroski: 2/9Altman Z: 1.60

TBCH

Hold

43

out of 100

Grade: D

Growth: 4.0Profit: 3.5Value: 5.0Quality: 7.0
Piotroski: 5/9Altman Z: 1.92
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLBTSignificantly Overvalued (-36.0%)

Margin of Safety

-36.0%

Fair Value

$10.92

Current Price

$15.07

$4.15 premium

UndervaluedFair: $10.92Overvalued

Intrinsic value data unavailable for TBCH.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLBT2 strengths · Avg: 9.0/10
Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
19.3%8/10

19.3% revenue growth

TBCH2 strengths · Avg: 8.0/10
PEG RatioValuation
0.988/10

Growing faster than its price suggests

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Areas to Watch

CLBT4 concerns · Avg: 2.8/10
Altman Z-ScoreHealth
1.604/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

P/E RatioValuation
54.9x2/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
-42.9%2/10

Earnings declined 42.9%

TBCH4 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.924/10

Grey zone — moderate risk

Market CapQuality
$258.21M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
1.1%3/10

ROE of 1.1% — below average capital efficiency

Profit MarginProfitability
0.4%3/10

0.4% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : CLBT

The strongest argument for CLBT centers on Debt/Equity, Revenue Growth. Revenue growth of 19.3% demonstrates continued momentum.

Bull Case : TBCH

The strongest argument for TBCH centers on PEG Ratio, Price/Book. PEG of 0.98 suggests the stock is reasonably priced for its growth.

Bear Case : CLBT

The primary concerns for CLBT are Altman Z-Score, Piotroski F-Score, P/E Ratio. A P/E of 54.9x leaves little room for execution misses.

Bear Case : TBCH

The primary concerns for TBCH are Altman Z-Score, Market Cap, Return on Equity. A P/E of 650.5x leaves little room for execution misses. Thin 0.4% margins leave little buffer for downturns.

Key Dynamics to Monitor

CLBT profiles as a growth stock while TBCH is a value play — different risk/reward profiles.

TBCH carries more volatility with a beta of 2.28 — expect wider price swings.

CLBT is growing revenue faster at 19.3% — sustainability is the question.

TBCH generates stronger free cash flow (29M), providing more financial flexibility.

Bottom Line

TBCH scores higher overall (43/100 vs 40/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cellebrite DI

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Cellebrite DI Ltd. provides digital intelligence solutions for the public and private sectors globally. The company is headquartered in Petah Tikva, Israel.

Turtle Beach Corporation

TECHNOLOGY · CONSUMER ELECTRONICS · USA

Turtle Beach Corporation is an audio technology company in North America, Europe, the Middle East, and the Asia Pacific. The company is headquartered in White Plains, New York.

Visit Website →

Want to dig deeper into these stocks?